Insilico Medicine (“Insilico”), a clinical-stage end-to-end generative artificial intelligence (AI) drug discovery company, has achieved a significant breakthrough in the application of multiple generative AI models and AlphaFold structures for drug discovery.
Bedfont® Scientific Limited Concludes the Shaun in the Heart of Kent Trail by Presenting a CELLER8® Device to a Successful Participant
The Shaun in the Heart of Kent art trail, sponsored by Bedfont®, unites the community while supporting Heart of Kent Hospice and promoting health with
January 2, 2025